Advances in Nuclear Cardiology: Instrumentation, Software and Radiopharmaceuticals
Journal Title: Nükleer Tıp Seminerleri - Year 2018, Vol 4, Issue 2
Abstract
Progress in equipment and software technology in nuclear medicine has contributed substantially to cardiac imaging. The most notable consequences of this progress are improvement in image quality and reduction in acquisition time and radiation dose. Introduction of new pharmaceuticals in parallel with the progress in equipment technology has enabled imaging of important molecular processes. This review summarizes the recent progress in equipment, software, and radiopharmaceuticals utilised in nuclear cardiac imaging and their contribution to diagnosis of cardiac disease.
Authors and Affiliations
Elif Özdemir, Deniz Bedel
Models of Cardiovascular Disease
Cardiovascular diseases are the leading causes of mortality and morbidity worldwide and account for the substantial proportion of global health burden. Since early diagnosis and treatment are important in disease course,...
Myocardial Viability and Molecular Imaging
Despite significant advances in cardiological diagnosis and treatment, heart failure is still an important cause of mortality and morbidity throughout the world. Noninvasive imaging techniques (echocardiography, magnetic...
Treatment of Intrahepatic Cholangiocellular Carcinoma with Y-90 Labelled Microspheres
Intrahepatic cholangiocellular carcinoma (ICC) is a rapidly progressive malignancy of intrahepatic bile duct epithelium. ICC is the second most common primary malignant tumor of the liver which accounts for 10% to 20% of...
Positron Emission Tomography/Magnetic Resonance Imaging and Technical Aspects
Integrated positron emission tomography integrated by/magnetic resonance (PET/MR) is one of the most important technical developments in the last decades. The endeavor of this article is to address up the general princip...
Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging in Diagnosis and Staging of Lung Cancer
Positron emission tomography/computed tomography (PET/CT) using fluorine-18 labelled fluorodeoxyglucose (FDG) is a powerful tool for managing patients with suspected lung nodules and lung cancer. In this review, we discu...